×
For best experience we recommend to activate Javascript in your browser.
Peroxiredoxin 2 antibody (AA 6-164)
This Rabbit Polyclonal antibody specifically detects Peroxiredoxin 2 in WB, IHC and ELISA. It exhibits reactivity toward Human.
Quick Overview for Peroxiredoxin 2 antibody (AA 6-164) (ABIN7570694)
Target
See all Peroxiredoxin 2 (PRDX2) Antibodies
Peroxiredoxin 2 (PRDX2)
Reactivity
All reactivities for Peroxiredoxin 2 antibodies
Human
Host
All hosts for Peroxiredoxin 2 antibodies
Rabbit
Clonality
All clonalities for Peroxiredoxin 2 antibodies
Polyclonal
Conjugate
All conjugates for Peroxiredoxin 2 antibodies
This Peroxiredoxin 2 antibody is un-conjugated
Application
All applications for Peroxiredoxin 2 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), ELISA
Product Details anti-Peroxiredoxin 2 Antibody
(hide)
Binding Specificity
All epitopes for Peroxiredoxin 2 antibodies
AA 6-164
Purpose
Anti-PRDX2 Polyclonal antibody
Purification
Antigen affinity purification.
Immunogen
E. coli - derived recombinant Human PRDX2 (Ala6-Tyr164).
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C,-80 °C
Storage Comment
Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
Target Details for Peroxiredoxin 2
(hide)
Target
Peroxiredoxin 2 (PRDX2)
Alternative Name
PRDX2
Background
Thiol-specific antioxidant protein,Natural killer cell-enhancing factor B,Peroxiredoxin-2,TDPX1,NKEF-B,Thioredoxin-dependent peroxiredoxin 2,TSA,Thioredoxin peroxidase 1,Thioredoxin-dependent peroxide reductase 1,PRP,PRDX2,NKEFB,
UniProt
P32119
Recently viewed
(hide)
Chat with us , powered by LiveChat